Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Not all hair loss patients are suitable for hair transplant due to various conditions like unstable hair loss, insufficient hair loss, very young age, unrealistic expectations, certain psychological disorders, and medical unfitness.

Asian women experiencing hair loss often feel embarrassed and unhappy, but hair transplantation can offer natural-looking results and improve their self-confidence.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

The study concluded that female pattern hair loss is linked to psychological distress and is hard to diagnose and treat, with its causes still not fully understood.

Most adult women experiencing hair loss are aged 21-40, with the most common type being female pattern hair loss. Trichoscopy is a useful tool for diagnosing different types of hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

The algorithm can effectively diagnose different types of female hair loss with proper history, examination, and tests.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Alopecia areata can look like male or female pattern hair loss, needing a new subtype for better diagnosis and treatment.

Researchers found new hair and nail genes, how hair reacts to UV, differences in white and pigmented hair growth, nerve changes in alopecia, treatments for baldness and alopecia, a toenail condition linked to a genetic disorder, and that nail fungus is more common in people with psoriasis.

Finasteride helps female-pattern hair loss.

Different women have various natural hairline shapes, and understanding this is important for designing hair transplants.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

A substance called prostaglandin D2 is linked to stopping hair growth in men with common baldness.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Hair loss linked to higher heart disease risk in both men and women.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.